Titanium dioxide in Cancer

What is it about?

Cancer is one of the most common diseases all over the world; many people suffer from diverse types of cancer. However, currently there is no exact cure or therapy developed for cancer. On the other hand, nanoparticles are defined as microscopic particles that have dimensions less than 100 nm and they are known with their usage in health sciences and medicine, however a few harmful effects on different animal cells, Therefore, researchers began to use nanoparticles for cancer therapies and to develop new methods for much more efficient therapies. Nanoparticles in cancer studies are commonly used in photodynamic therapy (PDT) and sonodynamic therapy (SDT) as a sensitizing agent, in computed tomography imaging (CT) and radiation therapy as an enhancement agent, in dual-mode image contrast and enhancement therapy as an image contrast agent. Titanium dioxide nanoparticles (TiO2 NPs) are known as a commonly used nanoparticles in medical applications and hence in cancer studies. They are used in PDT, SDT and drug delivery systems. As the cancer continues to affect people, new therapeutics and therapies will be developed and nanotechnology for this aim will be an important approach for the researchers.

Featured Image

Why is it important?

As the cancer incidence increases; new drugs, compounds and materials will be developed in the future. Until an exact and the most efficient therapy or treatment is found, the scientists will continue to seek new methods and approaches for cancer patients. With the developing technologies, much cheaper and much more reliable therapies could be applied in clinics. Using TiO2 NPs in different tumours could be a novel approach in both diagnosis and therapy.